Comment diagnostiquer une tumeur corticosurrénalienne ?
Le diagnostic repose sur l'imagerie (CT, IRM) et les tests hormonaux.
Tumeurs corticosurrénaliennesImagerie médicale
#2
Quels tests hormonaux sont utilisés ?
Les tests mesurent les niveaux de cortisol, d'aldostérone et d'androgènes.
CortisolAldostérone
#3
Quels signes d'imagerie indiquent une tumeur ?
Une masse surrénalienne visible sur CT ou IRM peut indiquer une tumeur.
TomodensitométrieImagerie par résonance magnétique
#4
Est-ce que la biopsie est nécessaire ?
La biopsie n'est pas toujours nécessaire, souvent l'imagerie suffit.
BiopsieDiagnostic
#5
Quels symptômes peuvent alerter sur une tumeur ?
Des symptômes comme l'hypertension ou des changements hormonaux peuvent alerter.
HypertensionSymptômes
Symptômes
5
#1
Quels sont les symptômes courants des tumeurs corticosurrénaliennes ?
Les symptômes incluent hypertension, prise de poids, et changements d'humeur.
SymptômesHypertension
#2
Comment les tumeurs affectent-elles les hormones ?
Elles peuvent provoquer une surproduction d'hormones comme le cortisol.
HormonesCortisol
#3
Y a-t-il des symptômes spécifiques aux tumeurs malignes ?
Les tumeurs malignes peuvent causer douleur abdominale et perte de poids.
Tumeurs malignesPerte de poids
#4
Les tumeurs peuvent-elles causer des problèmes de peau ?
Oui, des changements cutanés comme l'acné ou la peau fine peuvent survenir.
Problèmes de peauAcné
#5
Les symptômes varient-ils selon l'âge ?
Oui, les symptômes peuvent varier selon l'âge et le sexe du patient.
ÂgeSexe
Prévention
5
#1
Peut-on prévenir les tumeurs corticosurrénaliennes ?
Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé.
PréventionSuivi médical
#2
Quels modes de vie peuvent réduire les risques ?
Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider.
Mode de vieAlimentation équilibrée
#3
Les antécédents familiaux influencent-ils le risque ?
Oui, des antécédents familiaux de néoplasies peuvent augmenter le risque.
Antécédents familiauxNéoplasies
#4
Le tabagisme est-il un facteur de risque ?
Le tabagisme peut être un facteur de risque pour plusieurs types de cancers.
TabagismeFacteurs de risque
#5
Les examens réguliers sont-ils importants ?
Oui, des examens réguliers peuvent aider à détecter des anomalies précocement.
Examens réguliersDétection précoce
Traitements
5
#1
Quels traitements sont disponibles pour ces tumeurs ?
Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie.
ChirurgieChimiothérapie
#2
Quand la chirurgie est-elle recommandée ?
La chirurgie est recommandée pour les tumeurs localisées et symptomatiques.
ChirurgieTumeurs corticosurrénaliennes
#3
La radiothérapie est-elle efficace ?
La radiothérapie peut être utilisée pour les tumeurs malignes non opérables.
RadiothérapieTumeurs malignes
#4
Quels médicaments sont utilisés dans le traitement ?
Des médicaments comme les inhibiteurs de stéroïdes peuvent être prescrits.
MédicamentsInhibiteurs de stéroïdes
#5
Y a-t-il des traitements hormonaux disponibles ?
Oui, des traitements hormonaux peuvent aider à réguler les déséquilibres.
Traitements hormonauxDéséquilibres hormonaux
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent des métastases, des déséquilibres hormonaux et des infections.
ComplicationsMétastases
#2
Les tumeurs peuvent-elles causer des problèmes cardiaques ?
Oui, l'hypertension causée par les tumeurs peut entraîner des problèmes cardiaques.
HypertensionProblèmes cardiaques
#3
Y a-t-il un risque de récidive après traitement ?
Oui, le risque de récidive dépend du type de tumeur et du traitement reçu.
RécidiveTraitement
#4
Les tumeurs peuvent-elles affecter la fertilité ?
Certaines tumeurs peuvent affecter la fertilité en perturbant les hormones.
FertilitéHormones
#5
Quelles sont les conséquences psychologiques possibles ?
Les patients peuvent éprouver de l'anxiété et de la dépression suite au diagnostic.
Conséquences psychologiquesAnxiété
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'obésité, l'hypertension et des antécédents familiaux.
Facteurs de risqueObésité
#2
L'âge joue-t-il un rôle dans le risque ?
Oui, le risque augmente généralement avec l'âge, surtout après 40 ans.
ÂgeRisque
#3
Les maladies endocriniennes augmentent-elles le risque ?
Certaines maladies endocriniennes, comme le syndrome de Cushing, peuvent augmenter le risque.
Maladies endocriniennesSyndrome de Cushing
#4
Le sexe influence-t-il le risque de tumeurs ?
Oui, certaines tumeurs sont plus fréquentes chez les femmes que chez les hommes.
SexeTumeurs corticosurrénaliennes
#5
Les expositions environnementales sont-elles un facteur ?
Oui, certaines expositions environnementales peuvent augmenter le risque de cancer.
Expositions environnementalesCancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs corticosurrénaliennes : Questions médicales les plus fréquentes",
"headline": "Tumeurs corticosurrénaliennes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs corticosurrénaliennes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2026-06-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs corticosurrénaliennes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs de la surrénale",
"url": "https://questionsmedicales.fr/mesh/D000310",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la surrénale",
"code": {
"@type": "MedicalCode",
"code": "D000310",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.344.078"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénome corticosurrénalien",
"alternateName": "Adrenocortical Adenoma",
"url": "https://questionsmedicales.fr/mesh/D018246",
"about": {
"@type": "MedicalCondition",
"name": "Adénome corticosurrénalien",
"code": {
"@type": "MedicalCode",
"code": "D018246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.344.078.265.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carcinome corticosurrénalien",
"alternateName": "Adrenocortical Carcinoma",
"url": "https://questionsmedicales.fr/mesh/D018268",
"about": {
"@type": "MedicalCondition",
"name": "Carcinome corticosurrénalien",
"code": {
"@type": "MedicalCode",
"code": "D018268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.344.078.265.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs corticosurrénaliennes",
"alternateName": "Adrenal Cortex Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D000306",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andreas Schedl",
"url": "https://questionsmedicales.fr/author/Andreas%20Schedl",
"affiliation": {
"@type": "Organization",
"name": "Université Côte d'Azur, Inserm, CNRS, Institut de Biologie Valrose, 06108 Nice, France."
}
},
{
"@type": "Person",
"name": "Ja Seung Koo",
"url": "https://questionsmedicales.fr/author/Ja%20Seung%20Koo",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Erick M Remer",
"url": "https://questionsmedicales.fr/author/Erick%20M%20Remer",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.)."
}
},
{
"@type": "Person",
"name": "Michael T Corwin",
"url": "https://questionsmedicales.fr/author/Michael%20T%20Corwin",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.)."
}
},
{
"@type": "Person",
"name": "Elaine M Caoili",
"url": "https://questionsmedicales.fr/author/Elaine%20M%20Caoili",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Classic congenital adrenal hyperplasia with unilateral functional adrenal cortical adenoma: case report.",
"datePublished": "2024-07-22",
"url": "https://questionsmedicales.fr/article/39034929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09513590.2024.2373741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Primary adrenal diffuse large B cell Lymphoma with Tumor thrombus in central adrenal vein: a case report and literature review.",
"datePublished": "2023-11-24",
"url": "https://questionsmedicales.fr/article/37996831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12902-023-01496-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oncocytic adrenal cortical adenoma: a benign lesion mimicking malignancy.",
"datePublished": "2024-06-08",
"url": "https://questionsmedicales.fr/article/38851224",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-259327"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adrenal tumors in patients with neuroendocrine neoplasms.",
"datePublished": "2024-04-06",
"url": "https://questionsmedicales.fr/article/38581593",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12020-024-03810-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.",
"datePublished": "2023-09-02",
"url": "https://questionsmedicales.fr/article/37682621",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004797"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs des glandes endocrines",
"item": "https://questionsmedicales.fr/mesh/D004701"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs de la surrénale",
"item": "https://questionsmedicales.fr/mesh/D000310"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs corticosurrénaliennes",
"item": "https://questionsmedicales.fr/mesh/D000306"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs corticosurrénaliennes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs corticosurrénaliennes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs corticosurrénaliennes",
"description": "Comment diagnostiquer une tumeur corticosurrénalienne ?\nQuels tests hormonaux sont utilisés ?\nQuels signes d'imagerie indiquent une tumeur ?\nEst-ce que la biopsie est nécessaire ?\nQuels symptômes peuvent alerter sur une tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs corticosurrénaliennes",
"description": "Quels sont les symptômes courants des tumeurs corticosurrénaliennes ?\nComment les tumeurs affectent-elles les hormones ?\nY a-t-il des symptômes spécifiques aux tumeurs malignes ?\nLes tumeurs peuvent-elles causer des problèmes de peau ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs corticosurrénaliennes",
"description": "Peut-on prévenir les tumeurs corticosurrénaliennes ?\nQuels modes de vie peuvent réduire les risques ?\nLes antécédents familiaux influencent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs corticosurrénaliennes",
"description": "Quels traitements sont disponibles pour ces tumeurs ?\nQuand la chirurgie est-elle recommandée ?\nLa radiothérapie est-elle efficace ?\nQuels médicaments sont utilisés dans le traitement ?\nY a-t-il des traitements hormonaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs corticosurrénaliennes",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs peuvent-elles causer des problèmes cardiaques ?\nY a-t-il un risque de récidive après traitement ?\nLes tumeurs peuvent-elles affecter la fertilité ?\nQuelles sont les conséquences psychologiques possibles ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs corticosurrénaliennes",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes maladies endocriniennes augmentent-elles le risque ?\nLe sexe influence-t-il le risque de tumeurs ?\nLes expositions environnementales sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D000306#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une tumeur corticosurrénalienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie (CT, IRM) et les tests hormonaux."
}
},
{
"@type": "Question",
"name": "Quels tests hormonaux sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests mesurent les niveaux de cortisol, d'aldostérone et d'androgènes."
}
},
{
"@type": "Question",
"name": "Quels signes d'imagerie indiquent une tumeur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une masse surrénalienne visible sur CT ou IRM peut indiquer une tumeur."
}
},
{
"@type": "Question",
"name": "Est-ce que la biopsie est nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie n'est pas toujours nécessaire, souvent l'imagerie suffit."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter sur une tumeur ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hypertension ou des changements hormonaux peuvent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs corticosurrénaliennes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent hypertension, prise de poids, et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles les hormones ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer une surproduction d'hormones comme le cortisol."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux tumeurs malignes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tumeurs malignes peuvent causer douleur abdominale et perte de poids."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles causer des problèmes de peau ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements cutanés comme l'acné ou la peau fine peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'âge et le sexe du patient."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs corticosurrénaliennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels modes de vie peuvent réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de néoplasies peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut être un facteur de risque pour plusieurs types de cancers."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces tumeurs ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée pour les tumeurs localisées et symptomatiques."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée pour les tumeurs malignes non opérables."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de stéroïdes peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements hormonaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements hormonaux peuvent aider à réguler les déséquilibres."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des métastases, des déséquilibres hormonaux et des infections."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hypertension causée par les tumeurs peut entraîner des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de récidive dépend du type de tumeur et du traitement reçu."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles affecter la fertilité ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines tumeurs peuvent affecter la fertilité en perturbant les hormones."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences psychologiques possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent éprouver de l'anxiété et de la dépression suite au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'hypertension et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout après 40 ans."
}
},
{
"@type": "Question",
"name": "Les maladies endocriniennes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies endocriniennes, comme le syndrome de Cushing, peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de tumeurs ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines tumeurs sont plus fréquentes chez les femmes que chez les hommes."
}
},
{
"@type": "Question",
"name": "Les expositions environnementales sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines expositions environnementales peuvent augmenter le risque de cancer."
}
}
]
}
]
}
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda MD, United States.
Molecular Genomics Core (MGC), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda MD, United States.
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
From the Department of Radiology, Division of Abdominal Imaging, Massachusetts General Hospital, Boston, MA (R.C., M.A.B.); Department of Radiology, Abdominal Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA (J.G.); Department of Radiology, Imaging Institute and Glickman Urological Institute, Cleveland Clinic, Cleveland, OH (E.M.R.); Department of Radiology, Mayo Clinic, Rochester, MN (P.N.); Department of Radiology, Center for Biomedical Imaging, NYU Grossman School of Medicine, NYU Langone Health, New York, NY (M.T.T.); Department of Radiology, Ohio State University Wexner Medical Center, Columbus, OH (C.E.H.); Department of Radiology, University of Alabama, Birmingham, AL (K.G.S.); Department of Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada (W.T., G.L., M.B.); Departments of Radiology (B.W.C., M.T.C.) and Surgery (M.J.C.), UC Davis Medical Center, Sacramento, CA; Department of Radiology (J.T.L.), Department of General Surgery (C.Y.L.), and Department of Pathology and Laboratory Medicine (J.C.D.), University of Kentucky, Lexington, KY; Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (M.A.S., K.M.E.); Department of Radiology, University of Michigan, Ann Arbor, MI (E.M.C.); and Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada (N.S.).
Publications dans "Tumeurs corticosurrénaliennes" :
Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda MD, United States.
Publications dans "Tumeurs corticosurrénaliennes" :
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders related to adrenal steroid biosynthesis, and mainly caused by mutations in the CYP21A2 gene encoding 21-hydroxylase. Ad...
Primary adrenal lymphoma (PAL) is a rare disease confined wholly or chiefly to extramural involvement. Tumor thrombus in the central adrenal vein, renal vein, and inferior vena cava has been reported ...
Adrenocortical tumours are rare in children and account for only 0.3%-0.4% of all neoplasms in childhood. They present with variable signs and symptoms, depending on the type of hormonal hypersecretio...
To study the prevalence of primary adrenal tumors and adrenal metastases in patients with neuroendocrine neoplasms (NENs) and describe these in detail. NENs can be further divided into neuroendocrine ...
A review of medical files was conducted for all patients who underwent a...
In total,...
Adrenal primary tumors and adrenal metastases are infrequent occurrences in patients with NEN. Most cases involved the presence of NEN metastasis upon the initial discovery of adrenal tumors. The over...
Bilateral adrenal glands synchronously involved by different types of pathologies are uncommon. An 80-year-old man underwent FDG PET/CT to evaluate bilateral adrenal masses, which were initially disco...
Endocrine-disrupting chemicals (EDCs) are exogenous substances known to interfere with endocrine homeostasis and promote adverse health outcomes. Their impact on the adrenal cortex, corticosteroids an...
Malakoplakia is a rare disorder 75% of the reported cases affect mainly the genitourinary tract, its occurrence in the adrenal gland is extremely rare....
A 65-year-old female patient presented to the emergency department for chronic abdominal pain. Radiographic and biochemical studies revealed a left adrenal incidentaloma and left adrenalectomy was per...
Malakoplakia is a rare disorder, with non-standardized treatment, medical and surgical therapies appear to be effective in treating the condition....
The 5th edition of WHO Classification of Endocrine and Neuroendocrine Tumors (2022) introduced many significant changes relevant to endocrine daily practice. In this newsletter, we summarize the notab...
Hematopoietic neoplasms can cause adrenal infarction. In cases of thrombosis occurring at uncommon sites, it is necessary to consider evaluating for the...
Adrenal infarction, a rare ailment, has been sporadically linked to hematopoietic neoplasms. A 46-year-old male encountered left adrenal infarction, which coincided with a progressive rise in platelet...
The extracellular matrix (ECM) comprises macromolecules that shape a complex three-dimensional network. Filling the intercellular space and playing a crucial role in the structure and function of tiss...